Astatinated trastuzumab, aputative agent for radionuclide immunotherapy of ErbB2-expressing tumours

Mikael I. Persson, L. Gedda, H. J. Jensen, H. Lundqvist, P. U. Malmström, V. Tolmachev

Research output: Contribution to journalArticlepeer-review

20 Citations (Scopus)

Fingerprint Dive into the research topics of 'Astatinated trastuzumab, aputative agent for radionuclide immunotherapy of ErbB2-expressing tumours'. Together they form a unique fingerprint.

Medicine & Life Sciences